{{Rsnum
|rsid=7506045
|Gene=IMPA2
|Chromosome=18
|position=11987273
|Orientation=plus
|GMAF=0.1556
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IMPA2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 90.3 | 9.7 | 0.0
| HCB | 46.7 | 43.1 | 10.2
| JPT | 69.9 | 26.5 | 3.5
| YRI | 71.9 | 25.3 | 2.7
| ASW | 64.9 | 31.6 | 3.5
| CHB | 46.7 | 43.1 | 10.2
| CHD | 38.5 | 48.6 | 12.8
| GIH | 83.2 | 16.8 | 0.0
| LWK | 70.9 | 27.3 | 1.8
| MEX | 70.7 | 27.6 | 1.7
| MKK | 56.4 | 40.4 | 3.2
| TSI | 83.3 | 15.7 | 1.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs7506045
|PubMedID=17434096
|Condition=Stroke
|Gene=IMPA2
|Risk Allele=
|pValue=7.00E-007
|OR=5.39
|95CI=2.77-10.5
|OA=1
}}

{{PMID Auto
|PMID=19647252
|Title=KCNK17 genetic variants in ischemic stroke
}}

{{PharmGKB
|RSID=rs7506045
|Name_s=
|Gene_s=IMPA2
|Feature=
|Evidence=PubMed ID:17434096; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release (Initial Sample Size: 259 cases, 269 controls; Replication Sample Size: NR). This variant is associated with Stroke.
|Drugs=
|Drug Classes=
|Diseases=Stroke
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356392
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7506045
|overall_frequency_n=20
|overall_frequency_d=128
|overall_frequency=0.15625
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=18
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}